GENVIP – Publications

Publications

Since 2007 GENVIP has published more than 430 publications

CHARACTERISTICS AND MANAGEMENT OF ADOLESCENTS ATTENDING THE ED WITH FEVER: A PROSPECTIVE MULTICENTRE STUDY

Borensztajn D, Hagedoorn NN, Carrol E, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon Torres F, Nijman R, Pokorn M, Rivero-Calle I, Tsolia M, Vermont C, Zavadska D, Zenz W, Zachariasse J, Moll HA; PERFORM Consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union.

Pubmed Full article

Doi:

BMJ Open

Factor de impacto:

Q2

Doi:

EVOLVING STRATEGIES FOR MENINGOCOCCAL VACCINATION IN EUROPE: OVERVIEW AND KEY DETERMINANTS FOR CURRENT AND FUTURE CONSIDERATIONS

Martinón-Torres F, Taha MK, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V

Pubmed Full article

Doi:

Pathog Glob Health

Factor de impacto:

Q2

Doi:

IMPROVING EMPIRIC ANTIBIOTIC PRESCRIBING IN PEDIATRIC BLOODSTREAM INFECTIONS: A POTENTIAL APPLICATION OF WEIGHTED-INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAMS (WISCA)

Cook A, Sharland M, Yau Y; PediBSI Group*, Bielicki J. (Martinón-Torres F)

Pubmed Full article

Doi:

Expert Rev Anti Infect Ther.

Factor de impacto:

Q1

Doi:

Vacunación pediátrica frente al COVID-19 y a pesar del COVID-19 [Pediatric vaccination against COVID-19 and despite COVID-19]

Martinón-Torres F

Pubmed Full article

Doi:

An Pediatr (Barc)

Factor de impacto:

Q4

Doi:

SHOCK INDEX IN THE EARLY ASSESSMENT OF FEBRILE CHILDREN AT THE EMERGENCY

Hagedoorn NN, Zachariasse JM, Borensztajn D, Adriaansens E, von Both U, Carrol ED, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA; PERFORM consortium

Pubmed Full article

Doi:

Arch Dis Child

Factor de impacto:

Q1

Doi:

NIRSEVIMAB FOR PREVENTION OF RSV IN HEALTHY LATE-PRETERM AND TERM INFANTS

Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group (Martinón-Torres F)

Pubmed Full article

Doi:

N Engl J Med

Factor de impacto:

Q1

Doi:

VESICULOBULLOUS SKIN REACTIONS INDUCED BY COVID-19 MRNA VACCINE: REPORT OF FOUR CASES AND REVIEW OF THE LITERATURE

Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, García-García B, González-Iglesias I, Alonso-Penanes P, González-Guerrero M, Gutiérrez-Palacios A, Miranda-Martínez E, Martinón-Torres F

Pubmed Full article

Doi:

Clin Exp Dermatol

Factor de impacto:

Q2

Doi:

EVALUATION OF THE BNT162B2 COVID-19 VACCINE IN CHILDREN 5 TO 11 YEARS OF AGE

Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW Jr, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. (Martinón-Torres F)

Pubmed Full article

Doi:

N Engl J Med

Factor de impacto:

Q1

Doi:

CORRIGENDUM: CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEOUS HETEROPLASIA

Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F

Pubmed Full article

Doi:

Front Pediatr

Factor de impacto:

Q1

Doi:

EARLY IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ON PEDIATRIC CLINICAL RESEARCH: A PAN-EUROPEAN AND CANADIAN SNAPSHOT IN TIME.

Mantha OL, Flamein F, Turner MA, Fernandes RM, Hankard R; Network of National Networks Study Group. (Martinón-Torres F)

Pubmed Full article

Doi:

J Pediatr

Factor de impacto:

Q1

Doi:

ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN

I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres

Hum Vaccine Immunother

Factor de impacto:

Q2

Doi:

Pubmed Full article

QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL

Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group

Pediatr Infect Dis J

Factor de impacto:

Doi:

Pubmed Full article

GENVIP is a research group dedicated to the study of infectious diseases and the development of vaccines using Omics tools.

The team is based in Santiago de Compostela, a historic World Heritage city with great cultural wealth and a long-established university tradition. The research group is part of the Health Research Institute of Santiago de Compostela [Instituto de Investigación Sanitaria de Santiago (IDIS)], an institution that brings together the strengths of the University of Santiago and the University Clinical Hospital of Santiago de Compostela.

Covid-19; parallel sequencing; NGS; exomes; whole-genome sequencing; gene expression; RNAseq; nanostring; proteomics; proteomics